World’s longest lasting
ICD & CRT-D range1,2,3,4
World’s longest
projected longevity1,2,3,4
Longevity is based on real-life
pacing conditions.5
Longevity
14.3 years
13.1 years
10.9 years
10 years
Extended Longevity.
Backed by Warranty.6
Warranty applies regardless of the
pacing conditions and therapy frequency.6
Warranty
11 years
9 years
7 years
6 years
Platinium™ vs. Enduralife™
Platinium™ outlasts Enduralife™
technology by 12% under comparable settings.4
for in-clinic FU checks
+12%
Longevity
Boston Scientific
Breakthrough Technology
That stands the test of time.
Capacitors
0
Energy wasted
Capacitors
Reforming-free capacitors
Battery
20%
Improved capacity*
Battery
Total battery capacity: 2.19Ah
Platinium™ has a built in security margin of a minimum of 10 months between RRT and EOL even under demanding conditions.7
Once RRT is reached, Platinium™ SonR CRT-D programmed with 100% atrial and BiV pacing will still have a minimum of 10 months remaining battery life and will be able to deliver 11 shocks.
*Versus previous ICD & CRT-D generation
Electronics
40%
Reduced intrinsic consumption*
Electronics
Intrinsic consumption: 6.2μA**
*Versus previous ICD & CRT-D generation
**indicated at 60bpm (μA on Vbat)
Reduce Healthcare Costs
Healthcare Cost Savings.
Device longevity has an important economic impact.
Extended longevity significantly decreases the cost of therapy.
Up to
21%
Savings
ICD
From 9
to 14 years
longevity
Up to
26%
Savings
CRT-D
From 6
to 10 years
longevity
Expected average savings per patient implanted over a 15-year time period.8
Hear it from the experts
References
Medtronic - VISIA™ AF MRI VR SureScan™ DVFB1D4 Device manual M961177A001 B 2015-07-02. EVERA™ XT DR DDBB1D4 Device manual M946302A001 F 2014-03-11. CLARIA™ MRI QUAD CRT-D SureScan™ DTMA2QQ Device manual M956980A001 B 2017-07-17.
Biotronik - ILIVIA™ 7 VR-T, VR-T DX, DR-T, HF-T, HF-T QP (ProMRI®) Technical Manual 417641 Revision: D (2016-08-09).
Saint Jude Medical - Bradycardia and Tachycardia Devices - Help Manual - June 2013 Art 60033180/A.
Boston Scientific - Physician’s technical manual RESONATE™ HF ICD, RESONATE™ EL ICD, PERCIVA™ HF ICD, PERCIVA™ EL ICD, CHARISMA™ EL ICD, VIGILANT™ EL ICD, MOMENTUM™ EL ICD – Implantable Cardiovertor Defibrillator - 360204-001 EN Europe 2016-09. Physician’s technical manual RESONATE™ HF CRT-D, RESONATE™ CRT-D, RESONATE™ X4 CRT-D, CHARISMA™ CRT-D, CHARISMA™ X4 CRT-D, VIGILANT™ CRT-D, VIGILANT™ X4 CRT-D, MOMENTUM™ CRT-D, MOMENTUM™ CRT-D X4 – Cardiac Resynchronization Therapy Defibrillator 360203-001 EN Europe 2016-09.
Functioning conditions for projected longevity (conditions based on Sorin data on file): SonR CRT-D models: Biventricular pacing in DDD mode, 30% in atrium, 100% in both ventricles, at 60min-1, 600Ω, A & RV pacing amplitude 2.5V, LV pacing amplitude 3V, 0.35ms, 3 max shocks per year, sensor OFF, SonR ON. CRT-D models: Biventricular pacing in DDD mode, 30% in atrium, 100% in both ventricles, at 60min-1, 600Ω, A & RV pacing amplitude 2.5V, LV pacing amplitude 3V, 0.35ms, 3 max shocks per year, sensor OFF. DR models: Pacing in SafeR mode, 30% in atrium, 6% in ventricle, at 60 min-1, 600Ω, 2.5V, 0.35ms, 4 max shocks per year, sensor OFF. VR models: Pacing in VVI mode 6% at 40min-1, 600Ω, 2.5V, 0.35ms, 4 max shocks per year, sensor OFF. Longevities are calculated by taking into account 6 months storage with the following conditions: Remote ON: daily check, 4 follow-ups and 5 full alert reports per year. RF telemetry ON: 45min for ICD / 120min for CRT-Ds at implant + 15min at discharge + 15min in-clinic quarterly FU.
For more details please refer to the following document supplied with the device: U666 - LIMITED WARRANTY for PLATINIUM ICD & CRT-D devices.
Under following conditions: SonR CRT-D models & CRT-D models: 100% atrial & biventricular pacing in DDD mode, 500Ω, with as-shipped settings, and deliver 11 shocks at 34J. DR models: 100% atrial & ventricular pacing in DDD mode, 500Ω, with as-shipped settings, and deliver 13 shocks at 34J. VR models: 100% pacing in VVI mode, 500Ω, with as-shipped settings, and deliver 15 shocks at 34J.
Boriani G, Braunschweig F, Deharo JC et al. Impact of extending device longevity on the long-term costs of implantable cardioverter defibrillator therapy: a modelling study with a 15-year time horizon. Europace. 2013 Oct;15(10):1453-62.